Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Adaptimmune Therapeutics plc. (8/1/19). "Press Release: Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update". Philadeliphia, PA & Oxfordshire.

Organisations Organisation Adaptimmune Therapeutics plc (Nasdaq: ADAP)
  Group Adaptimmune (Group)
  Organisation 2 Alpine Immune Sciences Inc. (Nasdaq: ALPN)
Products Product ADP-A2M4 SPEAR T-cell therapy
  Product 2 T cell therapy
Index term Index term Adaptimmune–Alpine Immune Sciences: cell therapy technology, 201905– collab + license to incorporte SIP + TIP technology into SPEAR T-cell therapies
Persons Person Noble, James (Adaptimmune 201909– Non-Executive Director before CEO before MediGene + Avidex)
  Person 2 Rawcliffe, Adrian (Ad) (Adaptimmune 201909– CEO joined 201503 as CFO before GSK)
     


   
Record changed: 2019-08-07

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Adaptimmune (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top